BeiGene Ltd (ONC)
250.47
-2.73
(-1.08%)
USD |
NASDAQ |
Mar 25, 16:00
250.98
+0.51
(+0.20%)
After-Hours: 20:00
BeiGene Total Assets (Quarterly): 5.921B for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Gilead Sciences Inc | 59.00B |
| Leap Therapeutics Inc | 65.05M |
| Catalyst Pharmaceuticals Inc | 851.41M |
| Exelixis Inc | 2.948B |
| Halozyme Therapeutics Inc | 2.063B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.589B |
| Shareholders Equity (Quarterly) | 3.332B |
| Debt to Equity Ratio | 0.3055 |
| Current Ratio | 1.802 |
| Net Debt Paydown Yield | -0.50% |